Compare Hedera (HBAR) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hedera vs Enzyme — how do they compare? Hedera trades at Rp1,223 (market cap Rp53,59T, Rp869,12M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Hedera is far larger — about 399537.8× Enzyme's market cap, and Hedera's supply is capped (43,8B / 50B HBAR (88%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Hedera for 55 Days and Enzyme for 28 Days on average.
| HBAR | MLN | |
|---|---|---|
Market Cap | Rp53,59T | Rp134,13M |
Volume (24h) | Rp869,12M | Rp104,56M |
Circulating Supply | 43,8B / 50B HBAR (88%) | 3,3M MLN |
Typical Hold Time | 55 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hedera (HBAR) is currently trading at Rp1,218.08 with a market cap of Rp53.17 trillion, exhibiting a bearish technical signal driven by moving averages. The token is near its pivot point of Rp1,211, with support at Rp1,194 and resistance at Rp1,235. Circulating supply is 43.8M out of 50M HBAR, with an 88% circulation rate. No major protocol updates or ecosystem news are noted recently.
Overall outlook is cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebounds from oversold RSI levels, while risks involve high volatility and regulatory uncertainties. Investors should monitor support levels and on-chain activity for signs of reversal.
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hedera
Hedera (HBAR) is the most used, sustainable, enterprise-grade public network for the decentralized economy that allows individuals and businesses to create powerful decentralized applications (DApps). Hedera Hashgraph isn’t built on top of a conventional blockchain. Instead, it introduces a completely novel type of distributed ledger technology known as a Hashgraph. This technology allows it to improve upon many blockchain-based alternatives in several key areas, including speed, cost, and scalability.
Read more on HBAR →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
